Skip to main content
Figure 1 | BMC Cancer

Figure 1

From: Differential expression of histone deacetylases HDAC1, 2 and 3 in human breast cancer - overexpression of HDAC2 and HDAC3 is associated with clinicopathological indicators of disease progression

Figure 1

Immunhistochemical expression of HDAC2. Low (1a) expression of HDAC2 in invasive breast cancer, in this sample, only a few tumor cells (≤ 20%) show a weak HDAC2 expression (IRS 2; magnification power 400). Figure 1a shows the predominant negative expression. High (1b) expression of HDAC2 in invasive breast cancer, most of the tumor cells (≤ 70%) show a strong expression of HDAC2 (IRS 9; magnification power 400). The inset shows a negative expression of HDAC2 in a palatine tonsil that serves as an internal negative control (magnification power 400).

Back to article page